Akonni Biosystems specializes in molecular diagnostics, focusing on the development and commercialization of integrated diagnostic instruments and consumables. Their flagship product, TruTip, is a nucleic acid extraction technology that offers high yield and cost-effective DNA/RNA extraction from various specimens. The TruPrepR system enhances purity and sensitivity compared to traditional methods, while the TruDiagnosis platform employs proprietary 3D gel drop microarray technology for rapid multiplexed analysis of infectious diseases. This platform is designed for both point-of-care and high-throughput laboratory settings, allowing for the simultaneous analysis of multiple targets in a single test, significantly reducing the time required for results.

Central to Akonni's innovation is the TruArray technology, which utilizes three-dimensional gel drop microarrays to improve hybridization efficiency and detection sensitivity. The unique design allows for a higher capacity of probe immobilization, leading to more accurate results at a lower cost. Additionally, Akonni has developed a proprietary integrated microfluidic microarray consumable (IMMC) that simplifies the testing process by eliminating the need for complex fluidic transfers and reducing contamination risks. Their manufacturing approach, including reel-to-reel production on plastic substrates, further enhances cost-effectiveness and scalability, positioning Akonni Biosystems as a leader in the molecular diagnostics field.

United States

Akonni Biosystems is a molecular diagnostics company that develops, and manufactures at scale, sophisticated yet low cost genetic testing devices for complex infectious diseases like multi-drug-resistant tuberculosis (MDR-TB). 

Our approach is based on a revolutionary gel-drop microarray platform, along with associated instrumentation for high yield sample preparation and multiplex array imaging/analysis.

Akonni Biosystems

Company Details